• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

限制型心脏表型是法裔加勒比地区瓦尔 122 异亮氨酸变异转甲状腺素蛋白淀粉样心肌病患者有氧能力受损的主要原因。

Restrictive cardiac phenotype as primary cause of impaired aerobic capacity in Afro-Caribbean patients with val122ile variant transthyretin amyloid cardiomyopathy.

机构信息

Department of Cardiology CHU Martinique, University Hospital of Martinique, Fort de France, France.

Cardiovascular Research Team EA7525, Antilles University, Pointe-à-Pitre, France.

出版信息

Amyloid. 2020 Sep;27(3):145-152. doi: 10.1080/13506129.2020.1722098. Epub 2020 Feb 5.

DOI:10.1080/13506129.2020.1722098
PMID:32024385
Abstract

Impaired aerobic capacity in cardiac amyloidosis patients may be related to limited inotropic myocardial reserve and heart rate (HR) response limiting cardiac output rise. This study sought to investigate whether chronotropic incompetence (CI) and blunted HR recovery would be prevalent in patients with mutant transthyretin (ATTRv) cardiomyopathy. Eighteen ATTRv (Val122Ile) patients (72 ± 8-year) and 15 age-matched controls (73 ± 3-year) were prospectively enrolled. Patients' medical records, pulmonary function and cardiopulmonary exercise testing, including non-invasive cardiac hemodynamics and chronotropic response were studied. Compared with age-matched controls, maximal workload (91 ± 8 65 ± 20 watts) and peak VO (19.5 ± 3.0 14.4 ± 4.1 mL.kg.min) were lower in ATTRv patients. Despite reaching similar age-predicted maximal HR, ATTRv patients displayed smaller changes in stroke volume (SV) index relative to change in VO (49 ± 26 67 ± 18%). Adequate chronotropic-metabolic index was prevalent in ATTRv patients. HR recovery, as percent decrease in peak HR at 1 and 3-min, was blunded ATTv patients. In Val122Ile ATTRv patients, chronotropic response was appropriate relative to exercise intensity with only few patients displaying CI. HR response to exercise was further characterised by blunted HR recovery in ATTRv patients suggesting lower parasympathetic activity and greater sympathetic stimulation compared with controls.

摘要

心脏淀粉样变患者的有氧能力受损可能与心肌收缩储备有限以及心率 (HR) 反应限制心输出量增加有关。本研究旨在探讨突变转甲状腺素蛋白 (ATTRv) 心肌病患者是否普遍存在变时功能不全 (CI) 和 HR 恢复迟钝。前瞻性纳入 18 名 ATTRv (Val122Ile) 患者(72 ± 8 岁)和 15 名年龄匹配的对照组(73 ± 3 岁)。研究了患者的病历、肺功能和心肺运动试验,包括无创性心脏血液动力学和变时反应。与年龄匹配的对照组相比,ATTRv 患者的最大工作量(91 ± 8 65 ± 20 瓦特)和峰值 VO(19.5 ± 3.0 14.4 ± 4.1 毫升/千克/分钟)较低。尽管达到了相似的年龄预测最大 HR,但 ATTRv 患者的 SV 指数相对于 VO 的变化较小(49 ± 26 67 ± 18%)。在 ATTRv 患者中,适当的变时代谢指数很常见。HR 恢复,即峰值 HR 在 1 分钟和 3 分钟时的百分比下降,在 ATTv 患者中较迟钝。在 Val122Ile ATTRv 患者中,变时反应与运动强度相对应,只有少数患者显示出 CI。与对照组相比,HR 对运动的反应进一步表现为 HR 恢复迟钝,这表明 HR 恢复迟钝,提示副交感神经活动较低,交感神经刺激较大。

相似文献

1
Restrictive cardiac phenotype as primary cause of impaired aerobic capacity in Afro-Caribbean patients with val122ile variant transthyretin amyloid cardiomyopathy.限制型心脏表型是法裔加勒比地区瓦尔 122 异亮氨酸变异转甲状腺素蛋白淀粉样心肌病患者有氧能力受损的主要原因。
Amyloid. 2020 Sep;27(3):145-152. doi: 10.1080/13506129.2020.1722098. Epub 2020 Feb 5.
2
Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy.老年转甲状腺素蛋白心肌病患者遗传性转甲状腺素蛋白淀粉样变性的频率。
Eur J Heart Fail. 2022 Dec;24(12):2367-2373. doi: 10.1002/ejhf.2658. Epub 2022 Sep 11.
3
Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?V142I 相关变异转甲状腺素蛋白淀粉样心肌病的深度表型分析:与野生型转甲状腺素蛋白淀粉样变性不同?
Eur J Heart Fail. 2024 Feb;26(2):383-393. doi: 10.1002/ejhf.3088. Epub 2024 Jan 28.
4
Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS.遗传性转甲状腺素蛋白淀粉样变性心肌病的性别相关风险:来自 THAOS 的研究结果。
JACC Heart Fail. 2021 Oct;9(10):736-746. doi: 10.1016/j.jchf.2021.05.005. Epub 2021 Aug 11.
5
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).转甲状腺素蛋白心脏淀粉样变性的基因型与表型:THAOS(转甲状腺素蛋白淀粉样变性结局调查)
J Am Coll Cardiol. 2016 Jul 12;68(2):161-72. doi: 10.1016/j.jacc.2016.03.596.
6
Exercise Hemodynamics and Mitochondrial Oxidative Capacity in Disease Stages of Wild-Type Transthyretin Amyloid Cardiomyopathy.野生型转甲状腺素蛋白淀粉样心肌病疾病阶段的运动血液动力学和线粒体氧化能力。
J Am Heart Assoc. 2024 Jul 2;13(13):e034213. doi: 10.1161/JAHA.124.034213. Epub 2024 Jun 27.
7
Cardiac sympathetic denervation in wild-type transthyretin amyloidosis.野生型转甲状腺素淀粉样变心肌病心脏去交感神经支配。
Amyloid. 2020 Dec;27(4):237-243. doi: 10.1080/13506129.2020.1769059. Epub 2020 May 22.
8
Mutant Thr95Ile Transthyretin-Related Cardiac Amyloidosis With Polyneuropathy.与多神经病相关的突变型苏氨酸95异亮氨酸转甲状腺素蛋白心脏淀粉样变性
Circ J. 2019 Oct 25;83(11):2328. doi: 10.1253/circj.CJ-19-0281. Epub 2019 Jun 26.
9
Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac Amyloidosis.英国非裔加勒比人心力衰竭:病因、结局与ATTR V122I型心脏淀粉样变性
Circ Heart Fail. 2016 Sep;9(9). doi: 10.1161/CIRCHEARTFAILURE.116.003352.
10
Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT.他法米替尼在遗传性和野生型转甲状腺素蛋白淀粉样心肌病患者中的疗效:来自ATTR-ACT 的进一步分析。
JACC Heart Fail. 2021 Feb;9(2):115-123. doi: 10.1016/j.jchf.2020.09.011. Epub 2020 Dec 9.

引用本文的文献

1
Advancing Cardiac Amyloidosis Care Through Insights from Cardiopulmonary Exercise Testing.通过心肺运动试验的见解推进心脏淀粉样变性病的治疗
J Clin Med. 2024 Nov 29;13(23):7285. doi: 10.3390/jcm13237285.
2
The ventilatory component of the muscle metaboreflex is overstimulated in transthyretin cardiac amyloidosis patients with poor aerobic capacity.在有氧能力较差的转甲状腺素蛋白心脏淀粉样变患者中,肌肉代谢反射的通气成分受到过度刺激。
Front Physiol. 2023 May 15;14:1174645. doi: 10.3389/fphys.2023.1174645. eCollection 2023.
3
Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review.
转甲状腺素蛋白淀粉样变心肌病中的每搏输出量和心肌收缩分数:一项系统评价。
Front Cardiovasc Med. 2023 Jan 27;10:1085824. doi: 10.3389/fcvm.2023.1085824. eCollection 2023.
4
Determinants of ventilatory inefficiency in transthyretin cardiac amyloidosis: The role of excessive ventilatory drive.转甲状腺素蛋白心脏淀粉样变性中通气效率低下的决定因素:过度通气驱动的作用。
Front Physiol. 2022 Oct 21;13:1002238. doi: 10.3389/fphys.2022.1002238. eCollection 2022.
5
Diagnostic and Prognostic Values of Cardiopulmonary Exercise Testing in Cardiac Amyloidosis.心肺运动试验在心脏淀粉样变性中的诊断和预后价值
Front Cardiovasc Med. 2022 Jun 6;9:898033. doi: 10.3389/fcvm.2022.898033. eCollection 2022.
6
Cerebral Ischemic Events: An Overlooked Complication of Transthyretin Cardiac Amyloidosis in Afro-Caribbean Patients.脑缺血事件:非洲加勒比裔患者转甲状腺素蛋白心脏淀粉样变被忽视的并发症
Front Neurol. 2022 May 19;13:878292. doi: 10.3389/fneur.2022.878292. eCollection 2022.
7
Soluble urokinase plasminogen activator receptor levels are predictive of COVID-19 severity in Afro-Caribbean patients.可溶性尿激酶型纤溶酶原激活物受体水平可预测 Afro-Caribbean 患者 COVID-19 的严重程度。
Biomark Med. 2022 Feb;16(3):169-177. doi: 10.2217/bmm-2021-0669. Epub 2022 Jan 27.
8
Prevalence and Outcomes of p.Val142Ile Amyloidosis Cardiomyopathy: A Systematic Review.瓦尔 142 异亮氨酸淀粉样变心肌病的患病率和结局:系统评价。
Circ Genom Precis Med. 2021 Oct;14(5):e003356. doi: 10.1161/CIRCGEN.121.003356. Epub 2021 Aug 31.